The
Medicines Evaluation Unit is a joint venture with a major university
hospital and covenants all profits (through its charitable status)
to support research and patient care in the National Health Service.
The MEU specialises in performing clinical trials (from Phase I
through to IV) in respiratory / inflammatory medicine and related
areas. With the company’s position within hospital premises
it has the advantages of easier patient recruitment, specialist
equipment and ITU access available, and is therefore ideally suited
to perform early phase exploratory studies.
The medical and scientific staff of the MEU have developed extensive
experience from working within the Pharmaceutical Industry of the
clinical development of many different compounds.
|
